OnabotulinumtoxinA for the treatment of neurogenic detrusor overactivity in children

AIMS: This study evaluated whether one (or more) of three doses of onabotulinumtoxinA were safe and effective to treat neurogenic detrusor overactivity (NDO) in children. METHODS: This was a 48‐week prospective, multicenter, randomized, double‐blind study in children (aged 5–17 years) with NDO and u...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neurourol Urodyn
Hoofdauteurs: Austin, Paul F., Franco, Israel, Dobremez, Eric, Kroll, Pawel, Titanji, Wilson, Geib, Till, Jenkins, Brenda, Hoebeke, Piet B.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2020
Onderwerpen:
Original Clinical Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7839517/
https://ncbi.nlm.nih.gov/pubmed/33305474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/nau.24588
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items